DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3837-3846

  Mwangi, Waithaka ^a   Brown, Wendy C ^a   Lewin, Harris A ^a   Howard, Chris J ^a   Hope, Jayne C ^a   Baszler, Timothy V ^a   Caplazi, Patrick ^a   Abbott, Jeffrey ^a   Palmer, Guy H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; DNA VACCINE; EPITOPE; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PLASMID DNA;

ANAPLASMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DNA VECTOR; DRUG EFFICACY; DRUG MECHANISM; EFFECTOR CELL; FETUS LIVER; IMMUNIZATION; IMMUNOPHARMACOLOGY; INOCULATION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; NONHUMAN; OUTBREEDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VACCINATION;

EID: 0036786495     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3837     Document Type: Article

References (52)

1. Tang, D. C., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152.
2. Watts, A. M., and R. C. Kennedy. 1999. DNA vaccination strategies against infectious diseases. Int. J. Parasitol. 29:1149.
3. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:927.
4. Danko, I., and J. A. Wolf. 1994. Direct gene transfer into muscle. Vaccine 12: 1499.
5. Wolff, J. A., J. J. Ludtke, G. Ascadi, P. Williams, and A. Jani. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363.
6. Yukio, S., M. Roman, H. Tighe, D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
7. Akiko, I., B. J. N. Stiernholm, A. K. Chan, N. L. Berinstein, and B. H. Barber. 1997. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:4591.
8. + T cell responses elicited by a bicistronic Hiv-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168:562.
9. Weiss, W. R., K. J. Ishii, R. C. Hedstrom, M. Sedegah, M. Ichino, K. Barnhart, D. Klinman, and S. L. Hoffman. 1998. A plasmid encoding murine granulocytemacrophage colony stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161:2325.
10. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, N. Jennifer, et al. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a Malaria DNA vaccine. Science 282:476.
11. Arulkanthan, A., W. C. Brown, T. C. McGuire, and D. P. Knowles. 1999. Biased immunoglobulins G1 isotype responses induced in cattle with DNA expressing msp1a of Anaplasma marginale. Infect. Immun. 67:3481.
12. + type 1 responses in humans by a malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 98:10817.
13. Leachman, S. A., R. E. Tigelaar, M. Shlyankevich, M. D. Slade, M. Irwin, E. Chang, T. C. Wu, W. Xiao, S. Pazhani, D. Zelterman, and J. L. Brandsma. 2000. Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus-rabbit model. J. Virol. 74:8700.
14. Correale, P., G. Campoccia, K. Y. Tsang, L. Micheli, M. G. Cusi, M. Sabatino, G. Bruni, S. Sestini, R. Petrioli, D. Pozzssere, et al. 2001. Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (molgramostim) and hr-IL-2: results from a phase 1b clinical trial. Eur. J. Cancer 37:892.
15. Maraskovsky, E., E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack, and H. MacKenna. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878.
16. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
17. Shurin, M. R., P. P. Pandharipande, T. D. Zorina, C. Halusciczak, V. M. Subbotin, O. Hunter, A. Brumfield, W. J. Storkus, E. Maraskovsky, and M. T. Lotze. 1997. Flt3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179:174.
18. Kaplan, G., G. Walsh, L. S. Guido, P. Meyn, R. A. Burkhardt, R. M. Abalos, J. Baker, P. A. Frindt, T. T. Fajardo, R. Celona, and Z. A. Cohn. 1992. Novel responses of human skin to intradermal recombinant granulocyte macrophage colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med. 175:1717.
19. Bowne, W. B., J. D. Wolchok, W. G. Hawkins, R. Srinivasan, P. Gregor, N. E. Blachere, Y. Moroi, M. E. Engelhorn, A. N. Houghton, and J. J. Lewis. 1999. Injection of DNA encoding granulocyte macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects. Cytokines Cell Mol. Ther. 5:217.
20. Daro, E., E. Butz, J. Smith, M. Teepe, C. Maliszewski, and H. MacKenna. 2002. Comparison of the functional properties of murine dendritic cells generated in vivo with FLT3 ligand, GM-CSF and FLT3 ligand plus GM-CSF. Cytokine 17:119.
21. Pulendran, B., J. L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C. R. Maliszewski. 1998. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J. Exp. Med. 188:2075.
22. Gregory, S. H., A. J. Sagnimeni, N. B. Zurowski, and A. W. Thomsom. 2001. Flt3 ligand pretreatment promotes protective immunity to Listeria monocytogenes. Cytokine 13:202.
23. Kremer, I. B., M. P. Gould, K. D. Cooper, and F. P. Heinzel. 2001. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous Leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69:673.
24. Kumar, S., F. Villinger, M. Oakley, J. C. Aguiar, T. R. Jones, R. C. Hedstrom, K. Gowda, J. Chute, A. Stowers, D. C. Kaslow, et al. 2002. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-γ and cytotoxic T cell responses in rhesus monkeys: immunostimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol. Lett. 81:13.
25. Hung, C. F., K. F Hsu, W. F. Cheng, C. Y. Chai, L. He, M. Ling, and T. C. Wu. 2001. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res. 61:1080.
26. Moore, A. C., W. P. Kong, B. K. Chakrabarti, and G. J. Nabel. 2002. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J. Virol. 76:243.
27. Allred, D. R., T. C. McGuire, G. H. Palmer, S. R. Leib, T. M. Harkins, T. F. McElwain, and A. F. Barbet. 1990. Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope in Anaplasma marginale. Proc. Natl. Acad. Sci. USA 87:3220.
28. Barbet, A. F., G. H. Palmer, P. L. Myler, and T. C. McGuire. 1987. Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide AM105L. Infect. Immun. 55:2428.
29. Palmer, G. H., F. R. Rurangirwa, K. M. Kocan, and W. C. Brown. 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today 15:281.
30. Palmer, G. H., and T. F. McElwain. 1995. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet. Parasitol. 57:233.
31. + T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect. Immun. 69:6853.
32. Palmer, G. H., S. D. Waghela, A. F. Barbet, W. C. Davis, and T. C. McGuire. 1987. Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale. Int. J. Parasitol. 17:1279.
33. Mwangi, W., W. C. Brown, and G. H. Palmer. 2000. Identification of fetal liver tyrosine kinase 3 (flt3) ligand domain required for receptor binding and function using naturally occurring ligand isoforms. J. Immunol. 165:6966.
34. + T-cell responses to Mycobacterium bovis and M. avium antigens in bacille Calmette Guerin vaccinated and nonvaccinated cattle. Scand. J. Immunol. 52:285.
35. Edwards, C. P., and A. Aruffo. 1993. Current applications of COS cell based transient expression systems. Curr. Opin. Biotechnol. 4:558.
36. van Eijk, M. J. T., J. A. Stewart-Haynes, and H. A. Lewin. 1992. Extensive polymorphism of the BoLA-DRB3 gene distinguished by PCR-RFLP. Anim. Genet. 23:483.
37. MacHugh, N. D., A. Bensaid, W. C. Davis, C. J. Howard, K. R. Parsons, B. Jones, and A. Kaushal. 1988. Characterization of a bovine thymic differentiation antigen analogous to CD1 in the human. Scand. J. Immunol. 27:541.
38. Kemshead, J. T., L. Heath, F. M. Gibson, F. Katz, F. Richmond, J. Treleaven, and J. Ugelstad. 1986. Magnetic microspheres and monoclonal antibodies for depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations. Br. J. Cancer 54:771.
39. + T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66:5406.
40. + T lymphocyte epitopes that elicit strong recall responses. J. Immunol. 166:1114.
41. Kwong, L. S., J. C. Hope, M. L. Thom, P. Sopp, S. Duggan, G. P. Bembridge, and C. J. Howard. 2002. Development of an ELISA for bovine IL-10. Vet. Immunol. Immunopathol. 85:213.
42. Shoda, L. K. M., D. S. Zarlenga, A. Hirano, and W. C. Brown. 1999. Cloning of a cDNA encoding bovine interleukin-18 and analysis of IL-18 expression in macrophages and its IFN-γ-inducing activity. J. Interferon Cytokine Res. 19: 1169.
43. Kalyuzhny, A., and S. Stark. 2001. A simple method to reduce the background and improve well-to-well reproducibility of staining in ELISPOT assays. J. Immunol. Methods 257:93.
44. Haddad, D., J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, S. Kumar, S. L. Hoffman, and W. R. Weiss. 2000. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscle. J. Immunol. 165:3772.
45. Sun, X., L. M. Hodge, H. P. Jones, L. Tabor, and J. W. Simecka. 2002. Co-expression of granulocyte-macrophage stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination. Vaccine 20: 1466.
46. Stich, R. W., K. M. Shoda, M. Dreewes, B. Adler, T. W. Jungi, and W. C. Brown. 1998. Stimulation of nitric oxide production in macrophages by Babesia bovis. Infect. Immun. 66:4130.
47. + T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulins G1 (IgG1) and IgG2 synthesis. Infect. Immun. 67:155.
48. Estes, D. M., N. M. Closser, and G. K. Allen. 1994. IFN-γ stimulates IgG2 production from bovine B cells costimulated with anti-μ and mitogen. Cell. Immunol. 154:287.
49. + T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3. Infect. Immun. 66:5414.
50. Palmer, G. H., A. F. Barbet, W. C. Davis, and T. C. McGuire. 1986. Immunization with an isolate-common surface protein protects cattle against anaplasmosis. Science 231:1299.
51. Palmer, G. H., A. F. Barbet, G. H. Cantor, and T. C. McGuire. 1989. Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate. Infect. Immun. 57:3666.
52. + T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a. Infect. Immun. In press.